Table 2. Treatment-emergent AEs... | American Society of Hematology

Table 2.

Treatment-emergent AEs occurring in ≥ 5 patients (15%), regardless of attribution

AEs	All patients (N = 27)
AEs	All grades	Grade ≥ 3*
Any AE	27 (100)	10 (37)
Nausea	25 (93)	3 (11)
Diarrhea	21 (78)	0
Vomiting	11 (41)	1 (4)
Fatigue	10 (37)	2 (7)
Constipation	9 (33)	0
Headache	8 (30)	0
Dizziness	7 (26)	0
Abdominal pain	6 (22)	0
Taste disorder	6 (22)	0
Decreased appetite	6 (22)	0
Insomnia	6 (22)	1 (4)
Anemia	5 (19)	0
Thrombocytopenia†	5 (19)	0

AEs	All patients (N = 27)
AEs	All grades	Grade ≥ 3*
Any AE	27 (100)	10 (37)
Nausea	25 (93)	3 (11)
Diarrhea	21 (78)	0
Vomiting	11 (41)	1 (4)
Fatigue	10 (37)	2 (7)
Constipation	9 (33)	0
Headache	8 (30)	0
Dizziness	7 (26)	0
Abdominal pain	6 (22)	0
Taste disorder	6 (22)	0
Decreased appetite	6 (22)	0
Insomnia	6 (22)	1 (4)
Anemia	5 (19)	0
Thrombocytopenia†	5 (19)	0

All data are n (%).

One grade 4 event (atrial fibrillation; n = 1), but no grade 5 events, occurred during the study.

Includes the terms “thrombocytopenia” and “platelet count decreased,” as defined by the Medical Dictionary for Regulatory Activities.